875 related articles for article (PubMed ID: 25415787)
1. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
Iwaszkiewicz KS; Hua S
Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition.
Hua S; Cabot PJ
Pain Physician; 2013; 16(3):E199-216. PubMed ID: 23703419
[TBL] [Abstract][Full Text] [Related]
3. Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis.
Hua S; Dias TH; Pepperall DG; Yang Y
Front Pharmacol; 2017; 8():503. PubMed ID: 28824428
[TBL] [Abstract][Full Text] [Related]
4. Topical application of a novel oxycodone gel formulation (tocopheryl phosphate mixture) in a rat model of peripheral inflammatory pain produces localized pain relief without significant systemic exposure.
Smith MT; Wyse BD; Edwards SR; El-Tamimy M; Gaetano G; Gavin P
J Pharm Sci; 2015 Jul; 104(7):2388-96. PubMed ID: 25995048
[TBL] [Abstract][Full Text] [Related]
5. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
7. Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation.
Sauer RS; Hackel D; Morschel L; Sahlbach H; Wang Y; Mousa SA; Roewer N; Brack A; Rittner HL
Mol Pain; 2014 Feb; 10():10. PubMed ID: 24499354
[TBL] [Abstract][Full Text] [Related]
8. TRPV1 promotes opioid analgesia during inflammation.
Basso L; Aboushousha R; Fan CY; Iftinca M; Melo H; Flynn R; Agosti F; Hollenberg MD; Thompson R; Bourinet E; Trang T; Altier C
Sci Signal; 2019 Apr; 12(575):. PubMed ID: 30940767
[TBL] [Abstract][Full Text] [Related]
9. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
Edwards SR; Mather LE; Smith MT
Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
[TBL] [Abstract][Full Text] [Related]
10. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
Zhou L; Zhang Q; Stein C; Schäfer M
J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
[TBL] [Abstract][Full Text] [Related]
11. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
12. Involvement of peripheral opioid mechanisms in electroacupuncture analgesia.
Zhang GG; Yu C; Lee W; Lao L; Ren K; Berman BM
Explore (NY); 2005 Sep; 1(5):365-71. PubMed ID: 16781567
[TBL] [Abstract][Full Text] [Related]
13. Complete Freund's adjuvant-induced reduction of exploratory activity in a novel environment as an objective nociceptive endpoint for sub-acute inflammatory pain model in rats.
Zhu CZ; Bannon AW; Joshi SK
Eur J Pain; 2015 Nov; 19(10):1527-36. PubMed ID: 25731687
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
Nozaki-Taguchi N; Yaksh TL
Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
[TBL] [Abstract][Full Text] [Related]
15. Tissue monocytes/macrophages in inflammation: hyperalgesia versus opioid-mediated peripheral antinociception.
Brack A; Labuz D; Schiltz A; Rittner HL; Machelska H; Schäfer M; Reszka R; Stein C
Anesthesiology; 2004 Jul; 101(1):204-11. PubMed ID: 15220792
[TBL] [Abstract][Full Text] [Related]
16. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
17. D2-like receptor agonist synergizes the μ-opioid agonist spinal antinociception in nociceptive, inflammatory and neuropathic models of pain in the rat.
Mercado-Reyes J; Almanza A; Segura-Chama P; Pellicer F; Mercado F
Eur J Pharmacol; 2019 Jun; 853():56-64. PubMed ID: 30876975
[TBL] [Abstract][Full Text] [Related]
18. Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice.
Bruce DJ; Peterson CD; Kitto KF; Akgün E; Lazzaroni S; Portoghese PS; Fairbanks CA; Wilcox GL
Anesthesiology; 2019 Sep; 131(3):649-663. PubMed ID: 31343460
[TBL] [Abstract][Full Text] [Related]
19. Long-term antinociception by electroacupuncture is mediated via peripheral opioid receptors in free-moving rats with inflammatory hyperalgesia.
Wang Y; Hackel D; Peng F; Rittner HL
Eur J Pain; 2013 Nov; 17(10):1447-57. PubMed ID: 23649949
[TBL] [Abstract][Full Text] [Related]
20. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity.
DeHaven-Hudkins DL; Burgos LC; Cassel JA; Daubert JD; DeHaven RN; Mansson E; Nagasaka H; Yu G; Yaksh T
J Pharmacol Exp Ther; 1999 Apr; 289(1):494-502. PubMed ID: 10087042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
